Early research (Phase 1)Study completedNCT02562989
What this trial is testing
[18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001)
Who this might be right for
Alzheimer's DiseaseAmnestic Mild Cognitive Impairment
Merck Sharp & Dohme LLC 13